Allison Rosen, MD, ScD, talks about using value-based insurance design as an incentive to improve type 2 diabetes outcomes.
Allison Rosen, MD, ScD, discusses the various patient and physician incentives that have been created to improve behavioral economics in diabetes. Dr. Rosen states that improving behavioral economics can be aimed toward patients by lower health insurance co-pays and toward physicians with a fee-for-service program.
Dr. Rosen says that in order to re-design health plans you have to identify patients with diabetes and able to target different incentives. For example, value-based insurance design (VBID) has recently had an uptake of programs that help reduce long-term complications and costs.
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen
Global Status of HIV/AIDS Pandemic Takes Center Stage in Opening Session
March 10th 2025The Conference on Retroviruses and Opportunistic Infections 2025 opened with a session dedicated to informing attendees about the progress, and lack of progress, that has been made in the fight against the HIV pandemic given the current political climate.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
HIVconsvX Vaccine Shows Safety, Immune Response in People on ART
March 10th 2025This research on a T-cell–targeting vaccine in HIV has implications for future study design to incorporate consideration of age and years on antiretroviral therapy (ART) to evaluate the level of immune reconstitution.
Read More